Antiproliferative effects of low-dose micronized progesterone
article
OA: closed
CC0
⤵ 2 in-corpus citations
AI-generated summary
This study investigated the antiproliferative effects of low-dose micronized progesterone in human endometrial cancer cells, revealing its potential to inhibit cell growth and induce apoptosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo study the pharmacodynamic effects of oral micronized P on endometrial maturation.DesignThis was a controlled, open, parallel group, pilot study.SettingThe experiment was performed in an outpatient academic clinical research unit.PatientsTwelve healthy, P-challenged, estrogen-primed, postmenopausal women participated in the study.InterventionsPatients were given 300 mg micronized P daily (8:00 A.M.) or twice (8:00 A.M. and 4:00 P.M.) daily from study days 1 through 14 after estrogen priming for 30 days. Blood samples were taken at 0, 0.5, 1, 1.5, 2, 3, 4, 6, and 8 hours after the 8:00 A.M. dose on study day 1 and 14 and again at 8:00 and 9:30 A.M. on days 3 and 5 fasting, days 7 and 9 after a fatty meal, and day 11 after a high fiber meal. Endometrial biopsies were taken on day 1 and 14.Main outcome measuresProgesterone concentrations were measured. Endometrial biopsies were studied for effects on histology, glycogen content of glands, ribosomal RNA, and nuclear estrogen receptors in glands, surface epithelium, and stroma.ResultsDay 1 and 14 P kinetics were similar for 8 hours. Dose-dependent increases in glandular glycogen, decrease in ribosomal RNA, and decrease in nuclear estrogen receptors were demonstrated.ConclusionsOral micronized P can induce antiproliferative changes in the human endometrium at doses lower than those required for transformation of the endometrium to a full secretory state.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
- Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone 2002
- Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis—morphometric study 2003
References (28)
- doi:10.1016/0002-9378(89)90759-x via openalex
- doi:10.1016/s0015-0282(16)55916-0 via openalex
- W1536166167 via openalex
- W1587747486 via openalex
- W2033734515 via openalex
- W2108479208 via openalex
- doi:10.1136/bmj.280.6217.825 via openalex
- W2338862069 via openalex
- W2398950119 via openalex
- W2409942517 via openalex
- W6631790448 via openalex
- W6632102331 via openalex
- W6703724586 via openalex
- doi:10.1016/s0015-0282(16)54713-x via openalex
- doi:10.1016/0002-9378(88)90448-6 via openalex
- doi:10.1016/s0015-0282(16)48977-6 via openalex
- doi:10.1016/s0015-0282(16)56031-2 via openalex
- doi:10.1097/00006254-198908000-00018 via openalex
- doi:10.1016/s0015-0282(16)49576-2 via openalex
- doi:10.1210/jcem-69-4-917 via openalex
- doi:10.1093/oxfordjournals.humrep.a137092 via openalex
- doi:10.1007/bf01130781 via openalex
- doi:10.1093/labmed/10.12.772 via openalex
- doi:10.1136/bmj.287.6401.1241 via openalex
- doi:10.1093/oxfordjournals.humrep.a137138 via openalex
- doi:10.1016/s0015-0282(16)54680-9 via openalex
- doi:10.1016/0378-5122(94)90060-4 via openalex
- doi:10.1136/jcp.34.12.1406-c via openalex
Cited by (2)
- Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis—morphometric study 2003
- Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone 2002
Source provenance
- openalex
- last seen: 2026-05-11T04:43:15.460655+00:00
- unpaywall
- last seen: 2026-08-16T06:22:10.609676+00:00
License: CC0
· commercial use OK